Liliana Mendonça

Title: Liliana Mendonça: Innovator in Genetic Therapy

Introduction

Liliana Mendonça is a prominent inventor based in Coimbra, Portugal. She has made significant contributions to the field of genetic therapy, particularly in the treatment of neurodegenerative diseases. Her innovative work has garnered attention in the scientific community and beyond.

Latest Patents

Liliana holds a patent for an "Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias." This invention relates to a vector designed for use in treating polyglutamine repeat spinocerebellar ataxia, which includes cholesterol 24-hydroxylase encoding nucleic acid. This patent represents a crucial step forward in addressing complex genetic disorders.

Career Highlights

Throughout her career, Liliana has worked with notable organizations, including Brainvectis and the Institut National de la Santé et de la Recherche Médicale. Her experience in these institutions has allowed her to develop and refine her innovative ideas, contributing to advancements in medical research and therapy.

Collaborations

Liliana has collaborated with esteemed colleagues such as Sandro Alves and Nathalie Cartier-Lacave. These partnerships have facilitated the exchange of ideas and expertise, further enhancing her contributions to the field.

Conclusion

Liliana Mendonça's work exemplifies the spirit of innovation in genetic therapy. Her patent and collaborations highlight her commitment to advancing medical science and improving patient outcomes.